Monthly Archives: February 2013

The plot thickens

Diabetic Investor has learned that JAMA will be republishing a corrected version of Dr. Peter Butler’s commentary which was pulled from the JAMA Internal Medicine due to a factual error. What we still don’t know is who discovered this error … Continue reading

Posted in Email Alerts | Leave a comment

A sign of things to come

Yesterday Insulet (NASDAQ:PODD), who owns Neighborhood Diabetes announced that Neighborhood would no longer accept Medicare patients and would be exciting the Medicare business for diabetes testing supplies. With the new reimbursement rate set at under $11 for a box of … Continue reading

Posted in Email Alerts | Leave a comment

Some good news, some bad news

Now that Insulet (NASDAQ:PODD) has received FDA approval for their new smaller, less costly to make pod the company has cleared an important hurdle. That’s the good news. Unfortunately the impact of competitive bidding is hurting the company with one … Continue reading

Posted in Email Alerts | Leave a comment

Correction

In the just released note “The Butler Did It” – it has been brought to our attention there was typo – the sentence – “ Just as Dr. Frankenstein could not invasion the havoc he created when his experiment ended … Continue reading

Posted in Email Alerts | Leave a comment

The Butler Did It

According to Webster’s New World dictionary a zealot is defined as “a person who is zealous, esp. to an extreme or excessive degree; fanatic.” Unfortunately the diabetes world has been invaded by zealots before and based on the way things … Continue reading

Posted in Email Alerts | Leave a comment

Here we go again

Once again the issue of pancreatitis and GLP-1 therapy is rearing its ugly head thanks to a study published in the most recent  issue of Internal Medicine. The study; “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis … Continue reading

Posted in Email Alerts | Leave a comment

Inching towards the finish line

It seems with each passing day the FDA is inching closer to developing a path to approve a generic insulin. This past Friday FDA commissioner Margaret A. Hamburg, M.D. provided some additional insight to how this process might play out … Continue reading

Posted in Email Alerts | Leave a comment

Get with the program or get out of the way

Aldous Huxley once wrote; “Reality cannot be ignored except at a price; and the longer the ignorance is persisted in, the higher the and terrible becomes the price that must be paid.” Now Diabetic Investor knows Mr. Huxley was not … Continue reading

Posted in Email Alerts | Leave a comment

All part of the long term strategy

This past Friday Liberty Medical Supply which just completed a management buyout from Express Scripts back in December filed for Chapter 11 bankruptcy protection. According to various news reports the company listed assets and debts of between $100 million and … Continue reading

Posted in Email Alerts | Leave a comment

When will they learn?

This morning Medtronic (NYSE:MDT) released third quarter results which were less than spectacular for their diabetes unit which grew by less than 5%. According to the company’s earnings announcement; “Diabetes revenue of $377 million grew 3 percent on both a … Continue reading

Posted in Email Alerts | Leave a comment